Skip to main content

Evidence to Improve Care

Heavy Menstrual Bleeding

Care for Adults and Adolescents of Reproductive Age

Click below to see a list of brief quality statements and scroll down for more information.​​


Quality standards are sets of concise statements designed to help health care professionals easily and quickly know what care to provide, based on the best evidence. ​

See below for the quality statements and click for more detail.​


Quality Statement 1: Comprehensive Initial Assessment
Patients with symptoms of heavy menstrual bleeding have a detailed history taken, gynecological exam, complete blood count test, and pregnancy test (if pregnancy is possible) during their initial assessment.


Quality Statement 2: Shared Decision-Making
Patients with heavy menstrual bleeding are provided with information on all potential treatment options and are supported in making an informed decision on the most appropriate treatments for them, based on their values, preferences, and goals, including their desire for future fertility.


Quality Statement 3: Pharmacological Treatments
Patients with heavy menstrual bleeding are offered a choice of non-hormonal and hormonal pharmacological treatment options.


Quality Statement 4: Endometrial Biopsy
Patients with heavy menstrual bleeding who exhibit risk factors for endometrial cancer or endometrial hyperplasia are offered an endometrial biopsy.


Quality Statement 5: Ultrasound Imaging
Patients with heavy menstrual bleeding who have suspected structural abnormalities based on a pelvic exam, or who have tried pharmacological treatment but have not had significant improvement in their symptoms, are offered an ultrasound of their uterus.


Quality Statement 6: Referral to a Gynecologist
Patients with heavy menstrual bleeding have a comprehensive initial assessment and pharmacological treatments offered prior to referral to a gynecologist. Once the referral has been made, patients are seen by the gynecologist within 3 months.


Quality Statement 7: Endometrial Ablation
Patients with heavy menstrual bleeding who do not wish to preserve their fertility are offered endometrial ablation. In the absence of structural abnormalities, patients have access to non-resectoscopic endometrial ablation techniques.


Quality Statement 8: Acute Heavy Menstrual Bleeding
Patients presenting acutely with uncontrolled heavy menstrual bleeding receive interventions to stop the bleeding, therapies to rapidly correct severe anemia, and an outpatient follow-up appointment with a health care professional at or immediately following their next period (roughly 4 weeks).


Quality Statement 9: Dilation and Curettage
Patients with heavy menstrual bleeding do not receive dilation and curettage unless they present acutely with uncontrolled bleeding and medical therapy is ineffective or contraindicated.


Quality Statement 10: Offering Hysterectomy
Patients with heavy menstrual bleeding are offered hysterectomy only after a documented discussion about other treatment options, or after other treatments have failed.


Quality Statement 11: Least Invasive Hysterectomy
Patients with heavy menstrual bleeding who have chosen to have a hysterectomy have it performed by the least invasive method possible.


Quality Statement 12: Treatment for Fibroids Causing Heavy Menstrual Bleeding
Patients with heavy menstrual bleeding related to fibroids are offered uterine artery embolization, myomectomy, and hysterectomy as treatment options.


Quality Statement 13: Bleeding Disorders in Adolescents
Adolescents with heavy menstrual bleeding are screened for risk of inherited bleeding disorder, using a structured assessment tool.


Quality Statement 14: Treatment of Anemia and Iron Deficiency
Patients with heavy menstrual bleeding who have been diagnosed with anemia or iron deficiency are treated with oral and/or intravenous iron.

12

Treatment for Fibroids Causing Heavy Menstrual Bleeding

Patients with heavy menstrual bleeding related to fibroids are offered uterine artery embolization, myomectomy, and hysterectomy as treatment options.


Fibroids are one of the primary causes of heavy menstrual bleeding. Uterine artery embolization, myomectomy, and hysterectomy are effective options for patients with symptomatic fibroids. Myomectomy and uterine artery embolization should be considered conservative treatment options in selected patients who have been counselled on the potential risks and benefits of each option. For patients who do not wish to preserve fertility and have been counselled about the risks and benefits of hysterectomy, this treatment can be offered (see Statements 10 and 11 for details).

Prior to any procedural intervention for fibroids, anemia management with oral or intravenous iron is recommended to optimize the patient’s hemoglobin level to greater than 120 g/L. Gonadotropin-releasing hormone analogues or selective progesterone-receptor modulators can be used to supress menstruation and facilitate minimally invasive approaches.

For Patients

If fibroids (non-cancerous growths) are causing your heavy menstrual bleeding, you should be offered a uterine artery embolization, myomectomy, or hysterectomy. Uterine artery embolization shrinks the fibroids by blocking their blood supply. Myomectomy is surgery to remove the fibroids. Hysterectomy is surgery to remove your uterus.


For Clinicians

Offer uterine artery embolization, myomectomy, and hysterectomy as treatment options to all patients with heavy menstrual bleeding related to fibroids. Ensure patients have all the information they need to make an informed choice. If your patient has a hemoglobin level of less than 120 g/L, use oral or intravenous iron to raise their hemoglobin above 120 g/L before the procedure.


For Health Services

Ensure systems, processes, and resources are in place such that patients have access to uterine artery embolization, myomectomy, and hysterectomy as treatment options for fibroids causing heavy menstrual bleeding. Ensure clinicians are aware of specialists who accept referrals for these procedures.

Process Indicator

Percentage of patients with heavy menstrual bleeding who had a diagnosis of fibroids and who were offered the following procedures: uterine artery embolization, myomectomy, and hysterectomy

  • Denominator: number of patients with heavy menstrual bleeding who had a diagnosis of fibroids

  • Numerator: number of patients in the denominator who were offered a choice of the following procedures:

    • Uterine artery embolization

    • Myomectomy

    • Hysterectomy

  • Data source: local data collection

Note: This indicator can be calculated as an overall percentage and by each listed procedure.

Let’s make our health system healthier

Join Our Patient, Family and Public Advisors Program

Patients, families and the public are central to improving health quality.


Claude Lurette and Kowsiya Vijayartnam, Health Quality Ontario Patient, Family and Caregiver Advisors Council Co-Chairs

Sign up for our newsletter

Are you passionate about quality health care for all Ontarians? Stay in-the-know about the newest programs, reports and news from Health Quality Ontario and sign up for our electronic newsletter.

Health Quality Connect - Health Quality Ontario's newsletter - on an iPad and a cell phone